Personalized Vaccination of Tumor‐Derived Antigens and STING Agonists for Specific Cancer Immunotherapy

Documenti analoghi

• Piezo‐STING Agonists Enhance Tumor Penetration and Catalytic‐immunotherapy
  di: Zhuo Li, et al.
  Pubblicazione: (2025)
• A Polymeric mRNA Vaccine Featuring Enhanced Site‐Specific mRNA Delivery and Inherent STING‐Stimulating Performance for Tumor Immunotherapy
  di: Xiaoya Guo, et al.
  Pubblicazione: (2025)
• Coacervate‐Derived Assembly of Poly(ethylene glycol) Nanoparticles for Combinational Tumor Therapy
  di: Hanru Liu, et al.
  Pubblicazione: (2025)
• Layer‐by‐Layer Deposition of Antigen Peptides on Bifidobacterium for Subintestinal Lymphatic System‐Guided Personalized Tumor Immunotherapy
  di: Zhu Chen, et al.
  Pubblicazione: (2025)
• A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer
  di: Kaiming Li, et al.
  Pubblicazione: (2024)